New consortium tackles genetic origins of neurodevelopmental and psychiatric disorders

Neurodevelopmental and psychiatric disorders (NPD) including schizophrenia, bipolar disorder, autism, and depression are detrimental to individuals, their families and society as a whole, and in many cases still lack effective treatments.

Many autoimmune disease patients struggle with diagnosis, costs, inattentive care

After years of debilitating bouts of fatigue, Beth VanOrden finally thought she had an answer to her problems in 2016 when she was diagnosed with

November 27, 2023

Study Suggests No Overall Increased Risk of MS Relapse After COVID Boosters

Overall, people with multiple sclerosis (MS) were not at increased risk of relapse after receiving booster doses of the COVID-19 vaccine, according to a large

August 16, 2024

Cybin Inc. Announces Positive End-Of-Phase 2 Meeting with FDA for CYB003 in Major Depressive Disorder and Phase 3 Program Design | Psychedelic Invest

Cybin Inc. announced a positive End-of-Phase 2 meeting with the FDA for CYB003, its deuterated psilocybin analog for the adjunctive treatment of Major Depressive Disorder

March 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.